A nanostructured titania bioceramic implantable device capable of drug delivery to the temporal lobe of the brain

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 300, Issue 1-2 SPEC. ISS., 2007, Pages 3-10

  Lopez T ^a   Ortiz, E ^a   Quintana, P ^b   Gonzalez R D ^c  

^a UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^b DEPARTAMENTO DE FÍSICA APLICADA   (Mexico)

^c Tulane University   (United States)

Author keywords

Controlled drug release; Epilepsy; Implantable devices; Titania reservoirs; Valproic acid

Indexed keywords

DRUG DELIVERY; NANOSTRUCTURED MATERIALS; NEUROLOGY; PATIENT TREATMENT; PORE SIZE; SOL-GEL PROCESS; SYNTHESIS (CHEMICAL); TITANIUM DIOXIDE;

CENTRAL NERVOUS SYSTEMS (CNS); EPILEPSY; IMPLANTABLE DEVICES; TITANIA RESERVOIRS; VALPROIC ACIDS;

BIOCERAMICS;

ANTICONVULSIVE AGENT; BIOCERAMICS; NANOMATERIAL; TITANIUM DIOXIDE; VALPROIC ACID;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG DOSE INCREASE; DRUG RELEASE; HIPPOCAMPUS; IMPLANT; IN VIVO STUDY; KINDLING; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SEIZURE; SYNTHESIS; TEMPORAL LOBE;

EID: 34247119088     PISSN: 09277757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2006.10.060     Document Type: Article

References (22)

1. 2 mixed oxides. J. Solid State Chem. 177 (2004) 1873-1885
2. Diaz A., Lopez T., Manjarez J., Basaldella E., Martinez-Blanes J.M., and Odriozola J.A. Growth of hydroxyapatite in a biocompatible mesoporous ordered silica. Acta Biomater. 2 (2006) 173-179
3. Pardridge W.M. Drug delivery to the brain. J. Cereb. Blood Flow Metabol. 17 (1997) 713-731
4. LaVan D.A., McGuire T., and Langer R. Small-scale systems for in vivo drug delivery. Nat. Biotechnol. 21 (2003) 1184-1191
5. Morishita M., Goto T., Nakamura K., Lowman A.M., Takayama K., and Peppas N.A. Novel oral insulin delivery systems based on complexation polymer hydrogels: Single and multiple administration studies in type 1 and 2 diabetic rats. J. Contr. Rel. 110 (2006) 587-594
6. Jain K.K. The role of nanobiotechnology in drug discovery. Drug Discovery Today 10 (2005) 1435-1442
7. Serchen S., and West J. Implantable, polymeric systems for modulated drug delivery. Adv. Drug Del. Rev. 54 (2002) 1225-1235
8. Daan J.A., Crommelin G.S., Jiskoot G.W., Stenekes R., Mastrobattista R., and Hennik W.E. Nanotechnological approaches for the delivery of macromolecules. J. Contr. Rel. 87 (2003) 81-88
9. 2 nanotubes by TEM. Opt. Mater. 27 7 (2005) 1270-1275
10. Toga A.W., Samai M., and Payne B.A. Digital rat brain: a computerized atlas. Brain Res. Bull. 22 2 (1989) 323-333
11. Goddard G.V. The development of epileptic seizures through brain stimulation at low intensity. Nature 214 (1967) 1020-1025
12. Pavlova T., Stepanichev M., and Gulyaeva N. Pentylenetetrazole kindling induces neuronal cyclin B1 expression in rat hippocampus. Neurosci. Lett. 392 1-2 (2006) 154-158
13. Luszczki J.J., Wojcik-Cwikla J., Andres M.M., and Czuczwar. Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis. Neuropsychopharmacology 30 (2005) 958-973
14. Macdonald R.L., and Barker J.L. Pentylenetetrazol and penicillin are selective antagonists of GABA-mediated post-synaptic inhibition in cultured mammalian neurons. Nature 267 (1977) 720-721
15. 2 and γ-alumina catalytic supports. J. Catal., 222 (1), 15 (2004) 152-166.
16. 2 studied by optical, FTIR and X-ray photoelectron spectroscopy: correlation to presence of surface states. Thin Solid Films 358 1-2 (2000) 122-130
17. Garczarek F., and Gerwert K. Functional waters in intraprotein proton transfer monitored by FTIR difference spectroscopy. Nature 439 (2006) 109-112
18. A. Peterson, T. Lopez, E. Ortiz Islas, R.D. Gonzalez Pore structures in an implantable sol-gel titania ceramic device used in controlled drug release applications: a modelling study. Appl. Surf. Sci., in press.
19. Fournier E., Passirant C., Montero-Menei C.N., and Benoit J.P. Biomaterials 24 (2003) 3311-3319
20. Tang L., and Eaton J.W. Am. J. Clin. Pathol. 103 (1995) 466-471
21. Anderson J.M., Niven H., Pelagalli J., Olanoff L.S., and Jones R.D. J. Biomed. Mater. Res. 15 (1981) 889-899
22. Streit W.J., Mrak R.E., and Griffin W.S.T. J. Neuroinflammation 1 (2004) 14-16